潤達醫療(603108.SH):第一期員工持股計劃存續期延長12個月
格隆匯11月25日丨潤達醫療(603108.SH)公佈,截至2016年11月17日,公司第一期員工持股計劃已通過“國金潤達惠員工持股1號定向資產管理計劃”完成認購公司非公開發行股票205.2萬股,約佔公司購買完成時總股本的0.64%,成交總金額為人民幣5909.76萬元。2017年5月,公司實施2016年度利潤分配方案,以資本公積金向全體股東每10股轉增8股,轉增後,國金潤達惠員工持股1號定向資產管理計劃持有369.36萬股公司股票。上述股票已於2019年11月18日上市流通,截至本公告披露日,公司第一期員工持股計劃持有數量未發生變動。
公司第一期員工持股計劃的存續期為48個月,其中前36個月為鎖定期,後12個月為解鎖期,自公司公告本次非公開發行的股票登記至本次員工持股計劃名下時起算。
鑑於公司第一期員工持股計劃存續期內,《上市公司大股東、董監高減持股份的若干規定》等法律法規、規章制度的頒佈,導致標的股票無法在本次員工持股計劃原存續期屆滿前全部變現,並且基於對公司未來持續穩定發展的信心及公司股票價值的判斷,公司第一期員工持股計劃存續期擬延長12個月,即延長至2021年11月17日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.